Skip to content

Psilocybin: all studies

Page 172 of 440: studies 1,711 to 1,720 of 4,392, newest first. Back to the psilocybin overview

Research

The Cap of Liberty: Roman Slavery, Cultural Memory, and Magic Mushrooms

Folklore September 1, 2016 Adrastos Omissi 1 citation

The commonest psychedelic mushroom growing naturally in Britain, Psilocybe semilanceata, is known in English as the Liberty Cap. This name, which references an ancient Roman social practice, has caused considerable speculation in modern literature. This article provides a conclusive etymology for how a magic mushroom acquired this obscure name.

DOI: 10.1080/0015587x.2016.1155371 (opens in new tab) Etymology Magic telescope Mushroom Speculation +3

Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences

Journal of Psychopharmacology August 31, 2016 Theresa M. Carbonaro, Matthew P. Bradstreet, Frederick S. Barrett et al. 541 citations

Acute and enduring adverse effects of psilocybin have been reported anecdotally, but have not been well characterized. For this study, 1993 individuals (mean age 30 yrs; 78% male) completed an online survey about their single most psychologically difficult or challenging experience (worst “bad trip”) after consuming psilocybin mushrooms. Thirty-nine percent rated it among the top five most...

It’s time to take psilocybin seriously as a possible treatment for substance use disorders

The American Journal of Drug and Alcohol Abuse August 24, 2016 Michael P. Bogenschutz 18 citations

In the current issue of the American Journal of Drug and Alcohol Abuse, Johnson et al. (1) provide long-term outcome data from a smoking cessation pilot study of a treatment model using 2–3 doses o...

DOI: 10.1080/00952990.2016.1200060 (opens in new tab) Psilocybin Substance use Substance abuse treatment Hallucinogen

Psilocybin for treating substance use disorders?

Expert Review of Neurotherapeutics August 10, 2016 Bas T.h. de Veen, Arnt Schellekens, Michel M. M. Verheij et al. 102 citations

Evidence based treatment for Substance use disorders (SUD) includes psychotherapy and pharmacotherapy. However, these are only partially effective. Hallucinogens, such as psilocybin, may represent potential new treatment options for SUD. This review provides a summary of (human) studies on the putative therapeutic effects of psilocybin, and discusses the receptor systems, brain regions and...

Long-term follow-up of psilocybin-facilitated smoking cessation

The American Journal of Drug and Alcohol Abuse July 21, 2016 Matthew W. Johnson, Albert Garcia‐romeu, Roland R. Griffiths 702 citations

BACKGROUND: A recent open-label pilot study (N = 15) found that two to three moderate to high doses (20 and 30 mg/70 kg) of the serotonin 2A receptor agonist, psilocybin, in combination with cognitive behavioral therapy (CBT) for smoking cessation, resulted in substantially higher 6-month smoking abstinence rates than are typically observed with other medications or CBT alone. OBJECTIVES: To...

DOI: 10.3109/00952990.2016.1170135 (opens in new tab) Psilocybin Hallucinogen Smoking cessation Term time

ChemInform Abstract: Observations Concerning the Synthesis of Tryptamine Homologues and Branched Tryptamine Derivatives via the Borrowing Hydrogen Process: Synthesis of Psilocin, Bufotenin, and Serotonin.

ChemInform July 1, 2016 Silvia Bartolucci, Michele Mari, Giovanni Di Gregorio et al.

AbstractThe selective indole alkylation reaction applying the Ir‐catalyzed‐borrowing hydrogen methodology and using amino alcohols (II), (V), (VII) as suitable nitrogen‐containing electrophiles is reported.

MAGIC MUSHROOMS: from sacred entheogen to Class A drug

Entertainment and Sports Law Journal June 27, 2016 Charlotte Walsh 2 citations

On July 18th, section 21 of the Drugs Act 2005 came into force: as a result, magic mushrooms are now classified as a Class A drug under the Misuse of Drugs Act 1971. Following a brief look at magic mushrooms and their effects, this paper charts their usage throughout history, from Saharan tribes in ancient times, through the psychedelic revolution of the 1960s, to the boom in (recently halted)...

DOI: 10.16997/eslj.100 (opens in new tab) Magic telescope Boom Context archaeology Traditional medicine +1

PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEG

The International Journal of Neuropsychopharmacology May 27, 2016 Filip Tylš, Michaela Viktorinová, Dominika Prokopcova et al. 10 citations

Objective: Schizophrenia patients have a higher prevalence of type 2 diabetes mellitus than the general population, and even first-episode, drug-naive (FEDN) patients with schizophrenia have shown a higher prevalence of impaired glucose tolerance (IGT) than the general population.We aimed to investigate the prevalence of abnormal glucose tolerance after glucose loading, and to examine the...

A Phenomenological Examination of Psilocybin and its Positive and Persisting Aftereffects

NeuroQuantology May 24, 2016 Joseph A. Zamaria 32 citations

This study is an examination of the positive and persisting psychological and behavioral aftereffects in eight individuals who reported consumption of psilocybin-containing mushrooms. Mushrooms containing psilocybin have been used for healing and spiritual purposes for thousands of years, and the therapeutic applications of psilocybin were scientifically examined beginning in the mid-20th...

DOI: 10.14704/nq.2016.14.2.943 (opens in new tab) Psilocybin Cognitive psychology Telepathy Hallucinogen +2